In the short term, genetic testing for MANS could be implemented readily by incorporating MBD4 into existing gene panels used in diagnostic testing for adenomatous polyposis, CRC, early-onset AML, and uveal melanoma. Here, MBD4 is linked to acute myeloid leukemia.